News Focus
News Focus
icon url

rmtd

04/02/09 10:54 AM

#1575 RE: rmtd #1574

Novartis has an option on pixantrone and, if exercised, would pay CTIC a $7.5M fee and up to $104M in registration and sales related milestones.

Stay tuned…